AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04344301 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Audio recording
Description: The investigators will audio record the visits of patients in the intervention group. An RA will enter the exam room and begin the recording with the patient's permission. The patient and clinician can choose to stop or start the recording at any time. Once the visit is complete, the RA will enter the room, turn off the recording, and bring the patient to a private room where the RA will follow standardized instructions demonstrating how to access recordings. Patient access to recordings will be possible via a secure web-based platform. Patients will also receive reminders to listen to their recordings.
Study NCT02488499 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coping Power
Description: 15 sessions of concurrent parent and child group treatment
Study NCT02488499 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Individualized Treatment
Description: 15 sessions of individualized child and parent treatment
Study NCT02336841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as usual + Recovery MANTRA
Description: Participants in this group will receive the guided self-help intervention including video-clips, a workbook, and guidance from peer mentors, and treatment as usual.
Study NCT02336841 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual + feedback
Description: Participants in this group will receive treatment as usual and feedback on their eating disorder symptoms.
Study NCT04409899 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood tests
Description: RT-PCR, D-dimer, CRP, procalcitonin, ferritin, complete haemogram
Study NCT02577744 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Noninvasive Ventilation
Description: Noninvasive ventilation for 15 minutes with EPAP set at 10 cmH2O and IPAP adjusted to maintain a tidal volume of 6 ml / kg ideal weight.
Study NCT02577744 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Expiratory Positive Air Pressure
Description: EPAP through facial mask with valve spring load for 15 minutes set at 10 cmH2O.
Study NCT00312221 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Buprenorphine
Description: Buprenorphine transdermal patch 5 mcg/h applied for 7-day wear
Study NCT00312221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Description: Buprenorphine transdermal patch 20 mcg/h applied for 7-day wear
Study NCT00312221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxycodone immediate-release
Description: Oxycodone immediate-release 40 mg (two 5-mg capsules every 6 hours).
Study NCT03612362 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Improved Injera Baking Biomass Stove
Description: Replacing of the Ethiopian traditional Injera baking biomass stove with improved baking biomass stove, the well-known commercially distributed type of baking stove in Ethiopia, will be the intervention for this study. Control HHs will continue to use the traditional baking biomass stove. Concerning intervention duration, since the life span of the Ethiopian improved baking stove is about 5 years, the length of the intervention period will be one year to account for seasonal factors that have major effect on both ARI incidence \& HAP level in Ethiopia as well as to maintain a balance between achieving a sufficiently long follow-up period for outcome measurements \& suitably short follow-up period to decrease attrition.
Study NCT04338373 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: 0.01% Atropine sulfate solution in Comfort Drops (AVIZOR S.A., Spain)
Description: nightly instillations of 0.01% Atropine sulfate solution in Comfort Drops (AVIZOR S.A., Spain) in both eyes for 12 months
Study NCT02179879 — intervention group
Intervention type: OTHER
Intervention: Video validation
Description: Video taping of anaesthetist (experts and novices) perfoming labor epidural.
Study NCT02403362 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EPO-018B
Study NCT04373954 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Forgiveness Therapy
Description: The Forgiveness Therapy model mainly includes four stages: uncovering, decision, work and deepening. The book 8 Keys to Forgiveness (2015, a forgiveness therapy manual authored by Dr. Enright) is the basis for the therapy as a way to ensure that the treatment is uniformly founded on the forgiveness process developed at the University of Wisconsin-Madison.
Study NCT04373954 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Forgiveness Therapy
Description: The Forgiveness Therapy model mainly includes four stages: uncovering, decision, work and deepening. The book 8 Keys to Forgiveness (2015, a forgiveness therapy manual authored by Dr. Enright) is the basis for the therapy as a way to ensure that the treatment is uniformly founded on the forgiveness process developed at the University of Wisconsin-Madison.
Study NCT04373954 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Carey Guides
Description: The Carey Guides is a primary educational program deliberately chosen and approved by the Department of Corrections in Wisconsin, in which all inmates are encouraged (not required) to complete as they work toward custody reduction. Some aspects emphasized in it include anti-social thinking, emotional regulation, moral reasoning, and so on. It is the basis for the control group therapy as a way to ensure that the treatment has a uniform process as it is taught in the Department of Corrections (DOC) prison system.
Study NCT02771314 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD9291
Description: AZD9291, 80 mg (tablets) once daily, administered orally in the fasted state
Study NCT01961375 — intervention group
Intervention type: DRUG
Intervention: Levonorgestrel- Intra Uterine System (BAY 86-5028_Mirena)
Description: Levonorgestrel 52 mg intrauterine system with release rate of upto 20 mcg/day, Intrauterine insertion
Study NCT02131675 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Boost shake
Description: Blood draw after mixed-meal consumption
Study NCT03419338 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sinus lift
Description: Using a lateral access, the Schneider membrane will be elevated using curettes allowing the insertion of graft material.
Study NCT03419338 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sinus lift
Description: Using a lateral access, the Schneider membrane will be elevated using curettes allowing the insertion of graft material.
Study NCT03419338 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical alveolus
Description: Using a round diamond bur, a surgical alveolus will be created on an toothless ridge region.
Study NCT03419338 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Inorganic bovine bone + newly forming bone
Description: Maxillary sinus lift will be done with inorganic bovine bone associated with newly forming bone. The newly forming bone will be collected from surgical alveolus previous prepared.
Study NCT03419338 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Inorganic bovine bone
Description: Maxillary sinus lift will be done with inorganic bovine bone.
Study NCT03419338 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Collagen membrane
Description: At the end of the sinus lift, a collagen membrane will be used to obliterate the graft inside the maxillary sinus.
Study NCT03419338 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Collagen membrane
Description: At the end of the sinus lift, a collagen membrane will be used to obliterate the graft inside the maxillary sinus.
Study NCT04534491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxybutynin (Oxytrol, BAY839380)
Description: Oxybutynin transdermal patch, 3.9 mg daily (Oxytrol Transdermal System)
Study NCT03000179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Avelumab through a vein once every 2 weeks
Study NCT00578110 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Glaucoma Diagnosis, Name: Neucodia
Description: Sensitivity and Specificity
Study NCT00578110 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Glaucoma Diagnosis, Name: Neucodia
Description: Sensitivity and Specificity
Study NCT01236105 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2624803
Description: Administered orally (po), once.
Study NCT01236105 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Activated Charcoal
Description: Administered po
Study NCT01954186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intravenous & intramuscular oxytocin
Description: intravenous or intramuscular 10 iu oxytocin
Study NCT01954186 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: after delivery of the fetus & when anterior shoulder seen
Description: oxytocin 10 iu after the delivery of the fetus or when the anterior shoulder was seen after the fetal head was delivered
Study NCT01135862 — intervention group
Intervention type: DRUG
Group type: NO_INTERVENTION
Intervention: platelets
Description: 6 packs of platelets will be administered
Study NCT01135862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: platelets
Description: 6 packs of platelets will be administered
Study NCT02695433 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Active
Description: Active Treatment Diet Plan
Study NCT02695433 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Control Diet Plan
Study NCT02170779 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Spasticity: Take Control
Description: 4 visits: baseline, view and discuss DVDs, practice stretching, outcome measures
Study NCT02170779 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: 2 visits: baseline followed by usual care of brochure for stretching then outcome measures
Study NCT04494139 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral and Canteen intervention
Description: Behavioral intervention: 16 weeks
Study NCT04494139 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Canteen
Description: Canteen changes to introduce health foods
Study NCT04494139 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Canteen
Description: Canteen changes to introduce health foods
Study NCT01480921 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based exercise training
Description: Participants in the home-based group will be advised to exercise, a minimum of 3 times per week, but will be encouraged to exercise a total of 5-7 days per week as per CACR and ACSM guidelines. Prescriptions will include the same elements of those for the hospital group:~* 5-10 min warm-up~* 30 min aerobic interval training (walking or stationary bicycle)~* 10 min cool-down~Home-based participants will be asked to record their exercise in an exercise log book and will receive bi-weekly telephone calls from exercise personnel to monitor progress, assess and document adherence, revise the exercise prescription if necessary and provide support and education. Patient safety will be monitored during each call and serious health concerns will be relayed, with the patient's permission, to their primary health provider. Patients in this group will be encouraged to call the exercise specialist or kinesiologist with concerns or questions throughout the study.
Study NCT01480921 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supervised hospital-based exercise training
Description: Patients in the hospital-based group will participate in supervised, on-site, group exercise sessions 3 times per week, but will be encouraged to exercise a total of 5-7 days per week as per CACR and ACSM guidelines. Trained exercise personnel (kinesiologists and exercise specialists) will supervise these sessions. Exercise sessions will include:~* 5-10 min of warm-up~* 30 min of aerobic interval training using stationary cycles, treadmills and arm ergometers~* 10 min of cool down~Exercise will be tracked by the participant in exercise log books.
Study NCT01968850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: alendronate/vitamin D
Description: once weekly 70mg oral dose of alendronate co-formulated with 5600IU vitamin D3 (cholecalciferol) for 24 weeks.
Study NCT01419782 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole-body vibration
Description: Frequency: 40 Hz, vibration amplitude: 2 mm, duration: 60 sec
Study NCT04198454 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Compression bandages
Description: Class I (20-30 mmHg) compression bandages or stocking
Study NCT04198454 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Compression bandages
Description: Class I (20-30 mmHg) compression bandages or stocking
Study NCT04198454 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard wound dressings
Description: Wound dressings alone consisting of gauze and skin tape to cover the wound
Study NCT04198454 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fractional ablative carbon dioxide laser
Description: Participant will have laser applied to their wound bed.
Study NCT02131909 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: mirror therapy
Description: During a session, the child performs a series of 10 single, bilateral and synchronous movements while viewing the reflected image
Study NCT02131909 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: bimanual rehabilitation exercises
Description: During a session, the child performs a series of 10 single, bilateral and synchronous movements while watching his two hands
Study NCT00750971 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immunoablation and Autologous Hematopoietic Stem Cell Transplantation
Description: Transplantation of purified CD34+ autologous hematopoietic stem cells mobilized with cyclophosphamide (200mg/m2)and G-CSF (10µg/kg/d) after immunoablation with cyclophosphamide (200mg/kg)and rabbit-antithymocyteglobulin (90mg/kg)
Study NCT01591525 — intervention group
Intervention type: BEHAVIORAL
Intervention: Education on regular visits to a Primary Care Provider
Description: one-on-one education about the importance of visiting a primary care provider (PCP) on a regular basis. Patients are also provided a list of PCP's accepting new patients within a 3 mile radius.
Study NCT00750971 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Immunoablation and Autologous Hematopoietic Stem Cell Transplantation
Description: Transplantation of purified CD34+ autologous hematopoietic stem cells mobilized with cyclophosphamide (200mg/m2)and G-CSF (10µg/kg/d) after immunoablation with cyclophosphamide (200mg/kg)and rabbit-antithymocyteglobulin (90mg/kg)
Study NCT00702325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide / formoterol fumarate (SYMBICORT)
Description: 160/4.5 μg x 2 actuations twice daily (bid)
Study NCT00702325 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Budesonide
Description: inhalation powder 180 μg x 2 inhalations bid (PULMICORT)
Study NCT03535714 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MANTR-a treatment
Description: MANTR-a treatment
Study NCT00972426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carteolol (Mikelan), timolol (Timoptol), latanoprost (Xalatan)
Description: Experimental: Mikelan, 1 drop/daily, for 8 weeks Active Comparator: Timoptol, 1 drop/daily, for 8 weeks
Study NCT00972426 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: carteolol (Mikelan), timolol (Timoptol), latanoprost (Xalatan)
Description: Experimental: Mikelan, 1 drop/daily, for 8 weeks Active Comparator: Timoptol, 1 drop/daily, for 8 weeks
Study NCT01507779 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IVACFLU
Description: IVACFLU is a whole virus vaccine, collected in a linear sucrose density gradient solution using a continuous flow centrifuge Alfpa Wassmann and inactivated with formaldehyde. It was formulated to contain 15 mcg hemagglutinin (HA) of influenza A/California/07/2009(H1N1)-like virus per 0.5 mL dose and filled in single dose vials.
Study NCT01507779 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Phosphate buffered saline (PBS), pH 7.2, in 0.5 ml single-dose vials.
Study NCT01318252 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AL-54478 0.005%
Study NCT01318252 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Latanoprost 0.005%
Study NCT01318252 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AL-54478 Vehicle
Description: Inactive ingredients used as a placebo comparator
Study NCT04012879 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: CD19 CART
Description: CD19 CART
Study NCT03368950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online Mindfulness Course
Description: An online mindfulness course guiding participants through all elements of Mindfulness-Based Cognitive Therapy (MBCT) and Mindfulness-Based Stress Reduction (MBSR). Ten easy-to-follow sessions with videos and interactive exercises led by leading mindfulness trainers.
Study NCT03368950 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Online Mindfulness Course
Description: An online mindfulness course guiding participants through all elements of Mindfulness-Based Cognitive Therapy (MBCT) and Mindfulness-Based Stress Reduction (MBSR). Ten easy-to-follow sessions with videos and interactive exercises led by leading mindfulness trainers.
Study NCT01727765 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: inspiratory muscle training
Description: Both groups will undertake six weeks of inspiratory muscle training (POWERbreathe, H\&B International Ltd, UK), six days per week, with the only difference being the load set on the inspiratory muscle training device. For the real inspiratory muscle training group this load will be set to around 50% of maximal inspiratory mouth pressure and for the sham inspiratory muscle training group this load will be set to around 5% of maximal inspiratory mouth pressure.
Study NCT01727765 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: inspiratory muscle training
Description: Both groups will undertake six weeks of inspiratory muscle training (POWERbreathe, H\&B International Ltd, UK), six days per week, with the only difference being the load set on the inspiratory muscle training device. For the real inspiratory muscle training group this load will be set to around 50% of maximal inspiratory mouth pressure and for the sham inspiratory muscle training group this load will be set to around 5% of maximal inspiratory mouth pressure.
Study NCT02556125 — intervention group
Intervention type: DEVICE
Intervention: Diaphragm pacing
Description: Intramuscular diaphragm implantation is achieved by a laparoscopic approach whereby phrenic motor points on the diaphragm are mapped to optimize electrode placement. The electrodes are threaded into the diaphragm muscle and wire leads are externalized and attached to a stimulation controller.
Study NCT02361944 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxygen - normoxia
Description: Titration of FIO2 to maintain normal hemoglobin oxygen saturation (95-97%)
Study NCT02361944 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen - hyperoxia
Description: Administration of 1.0 FIO2 during ventilation and 0.8 or above during cardiopulmonary bypass
Study NCT03742635 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: General Movements Assessment
Description: Prechtl's Assessment of General Movements (GMA) is a tool used in early infancy to identify infants at high risk of cerebral palsy and neurodevelopmental impairment. General movements are complex motor patterns that involve the entire body, moving fluidly in different directions through the arms, legs, and trunk with variable speed, amplitude, force and intensity. During fetal development, spontaneously generated motor patterns, including general movements, can already be observed. The GMA is a functional assessment of the maturing nervous system that takes advantage of the fact that typically developing infants will have a progression in their general movements. This pattern is characterized by a writhing pattern in the early weeks post-term, followed by the emergence of fidgety movements at 3-5 months of age.
Study NCT04029181 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Anti-CD8 PET imaging agent
Description: An imaging agent radiolabelled with 89Zr developed for in human PET imaging of CD8
Study NCT02910960 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Acquire EUS Biopsy Device
Description: At EUS, once the pancreatic mass is identified, patients will be randomized to undergo sampling using the 22G Acquire EUS Biopsy Device or SharkCore Biopsy System.
Study NCT02910960 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SharkCore Biopsy System
Description: At EUS, once the pancreatic mass is identified, patients will be randomized to undergo sampling using the 22G Acquire EUS Biopsy Device or SharkCore Biopsy System.
Study NCT00051285 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enoximone
Description: Participants receive oral enoximone
Study NCT00051285 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Enoximone placebo
Description: Participants receive placebo to match enoximone
Study NCT01982721 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Locking mechanism for prosthetic knee
Study NCT02053324 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: AvidinOX/ST2210
Description: One intralesion injection of AvidinOX followed by an intravenous infusion of ST2210